✦ LIBER ✦

Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas

✍ Scribed by Weidmann, E.; Neumann, A.; Fauth, F.; Atmaca, A.; Al-Batran, S. E.; Pauligk, C.; Jager, E.

Book ID: 111692450
Publisher: Oxford University Press
Year: 2011
Tongue: English
Weight: 107 KB
Volume: 22
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdq671

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility and pharmacokinetic study of

Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin’s lymphoma

✍ Michinori Ogura; Kiyoshi Ando; Masafumi Taniwaki; Takashi Watanabe; Toshiki Uchi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Combination of rituximab with chlorambuc

Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen

✍ Sachanas, Sotirios; Pangalis, Gerassimos A.; Vassilakopoulos, Theodoros P.; Kork 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 350 KB

Phase II Multicenter Study of Bendamusti

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

✍ Robinson, K. S.; Williams, M. E.; van der Jagt, R. H.; Cohen, P.; Herst, J. A.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 119 KB

Three cases of Pneumocystis jirovecii pn

Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin’s lymphoma

✍ Annemarie C. Venhuizen; Willem N. M. Hustinx; Arend-Jan van Houte; Gerda Veth; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

A phase II study of the combination of b

A phase II study of the combination of bevacizumab with cytotoxic chemotherapy, as first line treatment, in older patients with advanced/metastatic NSCLC (non-squamous)

✍ Pallis, A.G.; Vamvakas, L.; Karampeazis, A.; Polyzos, A.; Agelaki, S.; Kentepozi 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 66 KB

Rituximab (anti-CD20 monoclonal antibody

Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study

✍ Gerald Jäeger; Peter Neumeister; Ruth Brezinschek; Gerald Höfler; Franz Quehenbe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB